Randomized Controlled Trial Examining the Efficacy of Botulinum Toxin in Biopsy Scar Minimization

NCT05478551 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Scar
Hypertrophic Scar

Interventions

DRUG: Botulinum Toxin
DRUG: Normal saline

Sponsor

Henry Ford Health System